ANA PERDOMO: Open Payments
NPI 1972229854 · MARYSVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 18 payments from 10 companies in 2025. Trend: 2023 $310 · 2024 $546 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $259 |
| Gilead Sciences, Inc. | 2 | $248 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $150 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| PFIZER INC. | 1 | $120 |
| ABBVIE INC. | 4 | $88 |
| Alkermes, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $24 |
| Hologic Sales and Service, LLC | 1 | $18 |
Products named: Kerendia, MOUNJARO, NUCALA, FARXIGA, COMIRNATY, Descovy, UBRELVY, VIVITROL.
Industry payments across CA — which companies pay providers there.
